203 related articles for article (PubMed ID: 24947558)
1. Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles.
Lee WL; Guo WM; Ho VH; Saha A; Chong HC; Tan NS; Widjaja E; Tan EY; Loo SC
Small; 2014 Oct; 10(19):3986-96. PubMed ID: 24947558
[TBL] [Abstract][Full Text] [Related]
2. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
[TBL] [Abstract][Full Text] [Related]
3. Altering the drug release profiles of double-layered ternary-phase microparticles.
Lee WL; Loei C; Widjaja E; Loo SC
J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
[TBL] [Abstract][Full Text] [Related]
4. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
6. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
8. Designing multilayered particulate systems for tunable drug release profiles.
Lee WL; Yu PO; Hong M; Widjaja E; Loo SC
Acta Biomater; 2012 Jul; 8(6):2271-8. PubMed ID: 22342827
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Pollauf EJ; Kim KK; Pack DW
J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
[TBL] [Abstract][Full Text] [Related]
10. Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2.
Kang Y; Wu J; Yin G; Huang Z; Liao X; Yao Y; Ouyang P; Wang H; Yang Q
Langmuir; 2008 Jul; 24(14):7432-41. PubMed ID: 18547089
[TBL] [Abstract][Full Text] [Related]
11. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
12. Prolonging food shelf-life by dual actives release from multi-layered polymer particles.
Biswal AK; Saha S
Colloids Surf B Biointerfaces; 2019 Mar; 175():281-290. PubMed ID: 30551015
[TBL] [Abstract][Full Text] [Related]
13. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy.
Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN
Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620
[TBL] [Abstract][Full Text] [Related]
14. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
Lu J; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
[TBL] [Abstract][Full Text] [Related]
15. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability.
Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of double-walled microspheres for the sustained release of doxorubicin.
Tan EC; Lin R; Wang CH
J Colloid Interface Sci; 2005 Nov; 291(1):135-43. PubMed ID: 15964579
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
18. Release of hydrophilic drug from biodegradable polymer blends.
Tan LP; Hidayat A; Lao LL; Quah LF
J Biomater Sci Polym Ed; 2009; 20(10):1381-92. PubMed ID: 19622278
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of skin permeation retardants and enhancers: a comparative study of levothyroxine-loaded PNIPAM, PLA, PLGA and EC microparticles.
Azarbayjani AF; Khu JV; Chan YW; Chan SY
Biopharm Drug Dispos; 2011 Oct; 32(7):380-8. PubMed ID: 21815171
[TBL] [Abstract][Full Text] [Related]
20. Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents.
Indolfi L; Causa F; Giovino C; Ungaro F; Quaglia F; Netti PA
J Biomed Mater Res A; 2011 May; 97(2):201-11. PubMed ID: 21394898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
